Table 4. Associated factors with hypertension in people with acquired immunodeficiency syndrome in use of antiretroviral therapy according to the presence (n = 36) or absence (n = 172) of arterial hypertension. Fortaleza, Ceará, Brazil, 2015-2017.

Risk factors for arterial hypertension	Hypertension				OR*	95% CI†	Significance (Chi-square test)
	Present		Absent
	n	%	n	%
Age
> 45 years	20	55.5	51	29.6	2.97	1.42 - 6.18	P = 0.003
≤ 45 years	16	44.4	121	70.3	1
Sex
Male	27	75.0	120	69.7	1.30	0.57 - 2.96	P = 0.531
Female	9	25.0	52	30.2	1
Family history of hypertension
Yes	32	88.8	110	63.9	4.51	1.52 - 13.4	P = 0.003
No	4	11.1	62	36.0	1
Smoking
Yes	12	33.3	83	48.2	0.54	0.25 - 1.14	P = 0.102
No	24	66.6	89	51.7	1
Consumption of alcohol
Yes	15	41.6	69	40.1	1.07	0.51 - 2.21	P = 0.863
No	21	58.3	103	59.8	1
Physical activity
Yes	13	36.1	67	38.9	0.89	0.42 - 1.87	P = 0.750
No	23	63.8	105	61.0	1
Overweight (BMI‡ ≥ 25)
Yes	24	66.6	79	45.9	2.35	1.11 - 5.01	P = 0.024
No	12	33.3	93	54.0	1
Obesity (BMI‡ ≥ 30)
Yes	8	22.2	22	12.7	1.95	0.79 - 4.81	P = 0.143
No	28	77.7	150	87.2	1
Waist circumference
Increased	14	38.8	34	19.7	2.58	1.20 - 5.57	P = 0.013
Normal	22	61.1	138	80.2	1
CD4+ T lymphocytes count
< 350 cells/mm3§	7	19.4	41	23.8	0.77	0.31 - 1.89	P = 0.569
≥ 350 cells/mm3§	29	80.5	131	76.1	1
Time of diagnosis of HIV|| infection
> 3 years	34	94.4	142	82.5	3.59	0.82 - 15.77	P = 0.072
≤ 3 years	2	5.5	30	17.4	1
Time of antiretroviral therapy
> 36 months	31	86.1	91	52.9	5.52	2.05 - 14.86	P < 0.001
≤ 36 months	5	13.8	81	47.0	1

*OR: odds ratio; †CI: confidence interval; ‡BMI: body mass index; §mm3: cubic millimeters; ||HIV: human immunodeficiency virus